Quantum BioPharma Ltd. Class B Subordinate Voting Shares represents the equity interest in Quantum BioPharma Ltd., a Toronto-based biopharmaceutical company focused on developing and advancing biotech solutions for challenging neurodegenerative, metabolic, inflammatory, and alcohol misuse disorders. The company’s current activities center on a portfolio of drug candidates and related life sciences assets across its biopharmaceutical and strategic investments segments. Its Class B shares provide exposure to a company operating in specialty therapeutics and biomedical innovation, with a structure that includes subordinate voting rights relative to the company’s Class A multiple voting shares. Quantum BioPharma Ltd. serves institutional and retail market participants interested in the life sciences sector, where clinical development, intellectual property, and asset portfolio management are key parts of the business model.
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$0.00
Net Income (TTM)
-$25M
▼ -80.7% YoY
Op. Margin
–
ROIC
-132.65%
▼ -30.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$5M
▼ -19.8% YoY
Op. Cash Flow (TTM)
-$5M
▼ -19.8% YoY
Net Debt
-$488K
Net Cash Position
Cash & Equiv.
$2M
Continue Research
Peers
Biotechnology · Pick stocks to compare with QNTM
Held by ETFs
QNTM is in 1 US ETF. The largest of them, with QNTM's weight in each:
Quantum BioPharma Ltd. Class B Subordinate Voting Shares (QNTM) in three numbers
Questions about Quantum BioPharma Ltd. Class B Subordinate Voting Shares
Is Quantum BioPharma Ltd. Class B Subordinate Voting Shares a high-quality business?
Quantum BioPharma Ltd. Class B Subordinate Voting Shares scores 10 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 4 checks computed from company filings. Its best check is net debt at -$488226, and its weakest is return on capital at -132.7%. The Quality tab shows every check against its target.
Does Quantum BioPharma Ltd. Class B Subordinate Voting Shares (QNTM) pay a dividend?
No. Quantum BioPharma Ltd. Class B Subordinate Voting Shares (QNTM) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: company filings. Price: last close 4 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing QNTM
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.